Molecular mechanisms of glucocorticosteroid actions

Pulmonary Pharmacology and Therapeutics

Volumn 13, Issue 3, 2000, Pages 115-126

  Adcock, Ian M ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DEXAMETHASONE; ENZYME; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; HISTONE; MIFEPRISTONE; ONAPRISTONE; PROTEIN; RU 24858; RU 40066; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; CYTOKINE RELEASE; DEACETYLATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; GENE TARGETING; GENETIC TRANSCRIPTION; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HORMONE RESISTANCE; HUMAN; INFLAMMATION; LUNG DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 0033773479     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1006/pupt.2000.0243     Document Type: Review

References (121)

1. Efficacy of inhaled corticosteroids in asthma
2. Inhaled glucocorticoids for asthma
3. Glucocorticoid effects on the production and actions of immune cytokines
4. Glucocorticoids suppress the production of interleukin 4 by human lymphocytes
5. Inhibition of interleukin-5 gene expression by dexamethasone
6. Expression of eotaxin by human lung epithelial cells: Induction by cytokines and inhibition by glucocorticoids
7. Effects of a corticosteroid, budesonide, on alveolar macrophage and blood monocyte secretion of cytokines: Differential sensitivity of GM-CSF, IL-1 beta, and IL-6
8. Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms
9. A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation
10. Expression of interleukin 2, interferon-gamma, and the IL 2 receptor by human peripheral blood lymphocytes
11. Control of transcription by steroid hormones
12. Glucocorticoid receptor localization in normal and asthmatic lung
13. Glucocorticoid receptors in bronchial epithelial cells in asthma
14. Transcriptional control by nuclear receptors
15. Primary structure and expression of a functional human glucocorticosteroid receptor cDNA
16. Functional domains of the human glucocorticosteroid receptor
17. Phosphorylation of steroid hormone receptors
18. Crystallographic analysis of the interaction of the glucocorticosteroid receptor with DNA
19. Solution structure of the glucocorticosteroid receptor DNA-binding domain
20. Refined solution structure of the glucocorticosteroid receptor DNA-binding domain
21. Evidence that the 90-kDa heat shock protein is necessary for the steroid binding conformation of the L cell glucocorticosteroid receptor
22. Association of a 59-kilodalton immunophilin with the glucocorticosteroid receptor complex
23. Steroid hormone receptors: Interaction with deoxyribonucleic acid and transcription factors
24. Reduced levels of hsp90 compromise steroid receptor action in vivo
25. Nuclear localization of unoccupied receptors for glucocorticoids, estrogens, and progesterone in GH3 cells
26. Heat shock induces translocation to the nucleus of the unliganded glucocorticosteroid receptor
27. Nucleocytoplasmic trafficking of steroid-free glucocorticosteroid receptor
28. Glucocorticoid receptor phosphorylation: Overview, function and cell cycle-dependence
29. Okadaic acid inhibits glucocorticoid-induced apoptosis in T cell hybridomas at its late stage
30. Protein phosphatase types 1 and/or 2A regulate nucleocytoplasmic shuttling of glucocorticosteroid receptors
31. Inhibition by 1-(5isoquinolinesulfonyl)-2-methylpiperazine, an inhibitor of protein kinase C, of enzyme induction by glucocorticoid and of nuclear translocation of glucocorticoid-receptor complexes
32. Binding kinetics of budesonide to the human glucocorticosteroid receptor
33. Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene
34. Role of TATA-element in transcription from glucocorticosteroid receptorresponsive model promoters
35. Anti-inflammatory actions of glucocorticoids: Molecular mechanisms
36. Immunosuppression by glucocorticoids: Inhibition of NF-kappa B activity through induction of I kappa B synthesis
37. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids
38. Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaBalpha synthesis
39. I-kappaB alpha independent downregulation of NF-kappaB activity by glucocorticosteroid receptor
40. Effect of dexamethasone on interleukin- 1beta-(IL-1beta)-induced nuclear factor-kappaB (NF-kappaB) and kappaB-dependent transcription in epithelial cells
41. Lipocortin-1 and the control of arachidonic acid release in cell signalling. Glucocorticoids inhibit G protein-dependent activation of cPLA2 activity
42. Human recombinant lipocortin 1 (annexin 1) has anticoagulant activity on human plasma in vitro
43. Lipocortin-1: Cellular mechanisms and clinical relevance
44. Binding and inhibition studies on lipocortins using phosphatidylcholine vesicles and phospholipase A2 from snake venom, pancreas, and a macrophage-like cell line
45. Diversity of group types, regulation, and function of phospholipase A2
46. Beta-adrenergic receptors in hamster smooth muscle cells are transcriptionally regulated by glucocorticoids
47. Glucocorticosteroids increase beta 2-adrenergic receptor transcription in human lung
48. Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo
49. Interleukin-1 type II receptor: A decoy target for IL-1 that is regulated by IL-4
50. Corticosteroids induce intracellular interleukin-1 receptor antagonist type I expression by a human airway epithelial cell line
51. Glucocorticoids inhibit cytokine-mediated eosinophil survival
52. Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts
53. Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticosteroid receptor
54. A weak TATA box is a prerequisite for glucocorticoid-dependent repression of the osteocalcin gene
55. Transcriptional control. Sinful repression
56. Histone acetylation facilitates RNA polymerase II transcription of the Drosophila hsp26 gene in chromatin
57. Transcription: Gene control by targeted histone acetylation
58. CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription
59. The nuclear hormone receptor coactivator SRC-1 is a specific target of p300
60. A signature motif in transcriptional co-activators mediates binding to nuclear receptors
61. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function
62. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors
63. Different histone acetylation induced by glucocorticoids and IL-1β in human epithelial cells (A549)
64. Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone
65. Nuclear receptor/AP-1 interaction
66. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticosteroid receptor
67. Negative cross-talk between RelA and the glucocorticosteroid receptor: A possible mechanism for the anti-inflammatory action of glucocorticoids
68. The effects of glucocorticoids on phorbol ester and cytokine stimulated transcription factor activation in human lung
69. STAT3 acts as a co-activator of glucocorticosteroid receptor signaling
70. Functional interactions between Stat5 and the glucocorticosteroid receptor
71. Comparison of the transactivation domains of Stat5 and Stat6 in lymphoid cells and mammary epithelial cells
72. The transcriptional coactivators p300 and CBP are histone acetyltransferases
73. Effects of cell density and trichostatin A on the expression of HDAC1 and p57Kip2 in Hep 3B cells
74. Activation of cAMP and mitogen responsive genes relies on a common nuclear factor
75. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
76. Two contact regions between Statl and CBP/p300 in interferon gamma signaling
77. Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator
78. Nuclear receptor-binding sites of coactivators glucocorticosteroid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): Multiple motifs with different binding specificities
79. Phosphorylated CREB binds specifically to the nuclear protein CBP
80. CREB-binding protein/p300 are transcriptional coactivators of p65
81. Progesterone regulates transcription of the p21(WAF1) cyclin-dependent kinase inhibitor gene through Sp1 and CBP/p300
82. p300/cAMP-responsive element-binding protein interactions with ets-1 and ets-2 in the transcriptional activation of the human stromelysin promoter
83. A role for CREB binding protein and p300 transcriptional coactivators in Ets-1 transactivation functions
84. Nuclear factor of activated T cells (NFAT)-dependent transactivation regulated by the coactivators p300/CREB-binding protein (CBP)
85. Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300
86. Transcription factor-specific requirements for coactivators and their acetyltransferase functions
87. p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Star5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response
88. Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFNgamma-mediated signaling
89. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway
90. Glucocorticoid receptor down-regulates c-Jun amino terminal kinases induced by tumor necrosis factor alpha in fetal rat hepatocyte primary cultures
91. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: Glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK
92. Activation of the mitogen-activated protein kinase cascade is suppressed by low concentrations of dexamethasone in mast cells
93. Post-transcriptional regulation of granulocyte-macrophage colony-stimulating factor synthesis in murine T cells
94. Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: Evidence for post-transcriptional regulation
95. Repression of cyclooxygenase-2 and prostaglandin E2 release by dexamethasone occurs by transcriptional and post-transcriptional mechanisms involving loss of polyadenylated mRNA
96. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase
97. Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor-kappa B
98. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: Effect of inhaled glucocorticoid
99. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients
100. Glucocorticoid inhibition of RANTES expression in human lung epithelial cells
101. Expression of RANTES in human airway epithelial cells: Effect of corticosteroids and interleukin-4, -10 and -13
102. Expression of RANTES by human bronchial epithelial cells in vitro and in vivo and the effect of corticosteroids
103. Genomic organization and transcriptional regulation of the RANTES chemokine gene
104. A distinct modulating domain in glucocorticosteroid receptor monomers in the repression of activity of the transcription factor AP-1
105. Ligand-induced differentiation of glucocorticosteroid receptor (GR) transrepression and transactivation: Preferential targetting of NF-kB and lack of I-kB involvement
106. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit anti-inflammatory activity in vivo
107. DNA binding of the glucocorticosteroid receptor is not essential for survival
108. Steroid resistance in asthma
109. Reduced glucocorticoid binding affinity in asthma is related to ongoing allergic inflammation
110. Combination IL-2 and IL-4 reduces glucocorticosteroid receptor-binding affinity and T cell response to glucocorticoids
111. p38 mitogen activated protein kinase mediates IL-2 and IL-4 mediated changes in glucocorticosteroid receptor (GR) affinity
112. Differences in binding of glucocorticosteroid receptor to DNA in steroid-resistant asthma
113. Abnormal glucocorticosteroid receptor-activator protein 1 interaction in steroid-resistant asthma
114. Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes
115. Increased JUN kinase activity in peripheral blood monocytes from steroid-resistant asthmatic subjects
116. Hypothalamic-pituitary-adrenal axis in corticosteroid-resistant bronchial asthma
117. Regulation of glucocorticosteroid receptor expression
118. Mechanism of glucocorticosteroid receptor down-regulation by glucocorticoids
119. Decreased glucocorticosteroid receptor activity following glucocorticosteroid receptor antisense RNA gene fragment transfection
120. Transcription factors: A new frontier in drug discovery
121. Cyclosporin A and glucocorticiods interact synergistically in T-lymphocytes: Implications for asthma therapy